Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Contralateral Claims Study of Clareon Vivity Pro

NCT: NCT07484191 · ACTIVE_NOT_RECRUITING

NCT IDNCT07484191
StatusACTIVE_NOT_RECRUITING
Start Date2026-04-28
Completion2027-02
SponsorAlcon Research (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.

Frequently Asked Questions

What is Contralateral Claims Study of Clareon Vivity Pro?

Contralateral Claims Study of Clareon Vivity Pro is a clinical trial registered under NCT07484191. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07484191?

The current status of NCT07484191 (Contralateral Claims Study of Clareon Vivity Pro) is: ACTIVE_NOT_RECRUITING.

When did Contralateral Claims Study of Clareon Vivity Pro start?

Contralateral Claims Study of Clareon Vivity Pro started on 2026-04-28.

Related Devices

K161794CENTURION Vision System (Active SentryTM)Alcon Research, Ltd. K170520HyperVit Vitrectomy Probe, 23 GA, HyperVit Vitrectomy Probe, 25+, HyperVit Vitrectomy Probe, 27+Alcon Research, Ltd. K191650LEGION SystemAlcon Research, LLC PMA P150037Intraocular pressure lowering implantAlcon Research, Ltd. PMA P170034Intraocular pressure lowering implantAlcon Research, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑